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Abstract
Introduction: Nosocomial legionellosis has generally been described in immunodepressed patients, but Legionella
pneumophila serogroup 3 has rarely been identified as the causative agent.
Case presentation: We report the case of nosocomial L. pneumophila serogroup 3 pneumonia in a 70-year-old
Caucasian man with non-Hodgkin lymphoma. Diagnosis was carried out by culture and real-time polymerase chain
reaction of bronchoalveolar lavage fluid. The results of a urinary antigen test were negative. A hospital
environmental investigation revealed that the hospital water system was highly colonized by L. pneumophila
serogroups 3, 4, and 8. The hospital team involved in the prevention of infections was informed, long-term control
measures to reduce the environmental bacterial load were adopted, and clinical monitoring of legionellosis
occurrence in high-risk patients was performed. No further cases of Legionella pneumonia have been observed so
far.
Conclusions: In this report, we describe a case of legionellosis caused by L. pneumophila serogroup 3, which is not
usually a causative agent of nosocomial infection. Our research confirms the importance of carrying out cultures of
respiratory secretions to diagnose legionellosis and highlights the limited value of the urinary antigen test for
hospital infections, especially in immunocompromised patients. It also indicates that, to reduce the bacterial load
and prevent nosocomial legionellosis, appropriate control measures should be implemented with systematic
monitoring of hospital water systems.
Introduction
Legionnaires’ disease is often a hospital-acquired infec-
tion. In Italy, 9.2% of nosocomial cases were recorded in
2 0 0 9w i t haf a t a l i t yr a t e( 3 4 % )s i g n i f i c a n t l yh i g h e rt h a n
community-acquired cases (12%) [1]. This difference is
due to the patients’ state of immunodeficiency, which is
known to be an important risk factor in contracting
Legionella pneumonia. Often, hospital water systems are
colonized by Legionella and this contamination is
responsible for most cases of hospital-acquired legionel-
losis [2]. A link between the presence of the bacterium
in hospital water systems and nosocomial legionellosis
has been reported [3], suggesting that it is necessary to
sample hospital water routinely for Legionella and make
sure that this microorganism is not present in transplant
units or other wards with significantly immunosup-
pressed patients [4]. Sixteen serogroups of Legionella
pneumophila are known. Serogroup 1 is the most com-
mon in clinical and environmental isolates [5], whereas
L. pneumophila serogroup 3 has rarely been isolated in
immunocompromised patients [6].
Case presentation
In this report, a case of hospital-acquired pulmonary
legionellosis in an immunocompromised patient - a 70-
year-old Caucasian man - is described. Sixteen years
before he presented to us, he had a condition that was
diagnosed as low-grade non-Hodgkin lymphoma of the
B-cell small lymphocytic type (stage IV with mediastinal,
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involvement), and nine courses of combined polyche-
motherapy were administered with cyclophosphamide,
doxorubicin, vincristine, and prednisone. Four years
before he presented to us, lymphoma chemotherapy was
started again with cyclophosphamide and fludarabine
because of a progression of mesenteric involvement of
the disease. This regimen was interrupted four months
later because of toxicity, and 11 courses of alemtuzumab
were administered thereafter in the Oncology and
Hematology Clinic of our division.
Three years before he presented to us, he was dis-
charged from our ward after a two-week hospitalization
for fever and pancytopenia (first hospital admission of
this report). After seven days, he was hospitalized again,
in another ward of the same hospital, because of fever,
dyspnea, and bowel movements with loose stools (sec-
ond admission). A chest X-ray showed an inflammatory
infiltrate at the base of his right lung, and another slight
infiltration seemed to be spreading in the upper field of
his left lung. The results of laboratory tests were unre-
markable except for significant increases of erythrocyte
sedimentation rate and C-reactive protein, minimal
increases of aspartate aminotransferase and alanine ami-
notransferase, and mild anemia. The results of blood
cultures, a cytomegalovirus antigen test in serum, and a
Clostridium difficile toxin stool test were negative. A
course of empirical antibiotic therapy with piperacillin/
tazobactam plus ciprofloxacin was started. A rapid
defervescence ensued, and our patient was discharged
after an eight-day course of antibiotics. However, two
days after discharge, fever recurred and he was hospita-
lized again in our ward to investigate a possible oppor-
tunistic respiratory infection (third admission). He
appeared mildly ill and complained of pleuritic pain at
the base of his right lung when breathing deeply; a low-
grade fever was present, but his respiratory rate (20
breaths per minute), heart rate (88 beats per minute),
and blood pressure (120/70 mm Hg) were normal; his
arterial blood oxygen saturation was 96% while he was
breathing room air. Inspiratory crackles were evident
over his right lower lung field, but the results of the
physical examination were otherwise normal. Blood cul-
tures were requested in order to check for common
pathogens as an empiric antibiotic therapy was started
with piperacillin/tazobactam. However, several hours
after admission, his fever increased to over 38°C and
persisted for five days. Therefore, a chest computed
tomography (CT) scan and a bronchoscopy test with
bronchoalveolar lavage (BAL) were performed and,
although our patient’s general clinical condition
remained stable and blood culture results were negative,
beta-lactams were replaced with clarithromycin to pro-
vide antibacterial coverage against possible atypical
respiratory pathogens. The chest CT scan showed evi-
dence of an area of lung parenchymal consolidation in
his right lower lobe with adjacent ground-glass opacities
and micronodules. No lymphadenopathy was evident. A
microbiological examination of BAL fluid was negative
for common Gram-negative and Gram-positive patho-
gens, fungi, Nocardia spp., Mycobacterium tubercolosis,
Pneumocystis jiroveci, cytomegalovirus, adenovirus, and
respiratory syncytial virus, but Legionella was detected
after four days of incubation. For culture, BAL fluid,
undiluted or diluted (1:10) in trypticase soy broth, was
plated on a buffered charcoal yeast extract (BCYE) med-
ium with 0.1% alpha-ketoglutaric acid and on selective
BCYE agar medium supplemented with glycine, vanco-
mycin, polymyxin B, and cycloheximide (GVPC) (Becton
Dickinson, Milan, Italy). Colonies were identified as L.
pneumophila serogroup 3 by using the Dresden mono-
clonal antibody panel [7]. The results of real-time poly-
merase chain reaction (PCR) assays performed on DNA
extracted from BAL fluid were also positive for Legio-
nella spp. (Nanogen Advanced Diagnostic, Torino,
Italy). The results of urinary antigen tests for L. pneu-
mophila serogroup 1 (Binax, Portland, ME, USA) and
non-serogroup 1 (Biotest, Dreieich, Germany) were
negative.
A prompt clinical response was observed after clari-
thromycin treatment. Two days after the start of macro-
lide treatment, our patient was afebrile and had no
chest pain and his condition was generally improving
and remained so thereafter. A chest X-ray performed
two weeks later showed a slight reduction of right lung
opacity, and he was discharged after 20 days of hospital
stay while on clarithromycin therapy. This treatment
was continued for seven more days. A follow-up chest
CT scan obtained five weeks later revealed an almost
complete resolution of the previously documented right
lung consolidation and ground-glass areas.
An environmental investigation was carried out after
the isolation of the infectious agent. First of all, our
patient’s home water system was investigated for the
presence of L. pneumophila, but this pathogen was
found in neither the cold nor the hot water system (data
not shown). Given that the incubation time for L. pneu-
mophila is generally two to 10 days and that, six days
after being discharged from his first hospitalization (for
pancytopenia), our patient was admitted again with
respiratory symptoms, we suspected that he had been
exposed to the microorganism during the period spent
in the hospital. To verify this hypothesis, an intensive
environmental investigation was carried out on the hos-
pital’s hot and cold water systems. A microbiological
analysis of water samples, collected from the sink and
shower of our patient’sr o o mf r o mt h ef i r s th o s p i t a l
admission, revealed that the hot water sample was
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The concentration of 8000 colony-forming units per
liter (CFU/L) exceeded the 1000 CFU/L of the European
guidelines for hotels and the 1000 CFU/L of the Italian
guidelines for hospitals [8]. Also, a lot of other sites of
the hospital’s hot water system were highly colonized by
L. pneumophila, including serogroups 3, 4, and 8 (Table
2). Legionella was not isolated from the cold water sys-
tem. Molecular typing of L. pneumophila clinical and
environmental isolates was carried out by using the
amplified fragment length polymorphism method [9],
and the genomic profile of the L. pneumophila clinical
strain matched with that of the L. pneumophila ser-
ogroup 3 strain (data not shown).
On the basis of these results, an extensive program of
microbiological controls in the entire hospital water sys-
tem was implemented. In accordance with the European
guidelines, shock hyperchlorination was applied to the
water distribution system [10] with a single addition of
chlorine to the water to obtain concentrations of free
residual chlorine of 20 to 50 mg/L throughout the water
system, including the distal point. After this treatment,
cultures of water samples collected one day after hyper-
chlorination showed a decrease in L. pneumophila con-
centration. However, a considerable increase of CFU
was observed one month later (Table 3). Therefore, con-
tinuous hyperchlorination treatment (free residual
chlorine of 1 to 3 mg/L) of the hospital water system is
now routinely applied and monitoring is performed
every six months. In addition, periodic monitoring of
the Legionella CFU in the water system is carried out
along with careful clinical surveillance of legionellosis
cases in low- and high-risk patients with pneumonia.
No other nosocomial Legionella pneumonia cases have
been observed so far.
Discussion
Owing to the difficulty of distinguishing legionellosis
from other forms of pneumonia by clinical and roent-
genographic analysis, specific laboratory diagnostics
should be enforced in order to increase the detection
rate of nosocomial Legionnaires’ disease. Culture
remains the most specific diagnostic procedure for
legionellosis [5]. The usefulness of urinary antigen
detection for the diagnosis of Legionnaires’ disease is
well documented. However, because it is fast and easy
to perform, this test has caused a decrease in the use of
cultures to detect infection, resulting in incomplete sur-
veillance for legionellosis [5]. The Binax urinary antigen
kit detects L. pneumophila serogroup 1 antigen [11],
whereas the Biotest urine antigen enzyme immunoassay
has a wide range of cross-reactivity to the other ser-
ogroups and species. Benson and colleagues [12]
reported that both Binax and Biotest urinary antigen
kits were capable of detecting multiple serogroups of L.
pneumophila, including serogroup 3. However, in this
case and in other legionellosis cases [6], the urine anti-
gen test was negative when the above-mentioned kits
were used and the correct diagnosis was made only
when BAL fluid-specific culture and real-time PCR
methods were used. This demonstrates the importance
of using at least one of these methods as part of the
routine microbiological testing of BAL fluid, especially
in immunocompromised patients with pulmonary
Table 1 Microbiological analysis of hot water sampled
from our patient’s room from his first admission
Sampling
site
Sampling
mode
Legionella pneumophila load, CFU/
L
Bathroom sink Pre-flushing 4 × 10
3
Post-flushing 4.5 × 10
3
Shower Pre-flushing 4 × 10
2
Post-flushing 3.5 × 10
2
CFU/L: colony-forming units per liter.
Table 2 Microbiological analysis of hot water sampled from the entire water system of the hospital
Sampling site Sampling mode Legionella pneumophila load, CFU/L
Water mains Pre-flushing Not detected
Post-flushing Not detected
Hospital water harvesting tanks Pre-flushing Not detected
Post-flushing Not detected
Collector pipes Pre-flushing Not detected
Post-flushing Not detected
Boiler Pre-flushing 5 × 10
3
Post-flushing 4.5 × 10
3
Room closest to the boiler (sink) Pre-flushing 6.5 × 10
3
Post-flushing 7 × 10
3
Room farthest from the boiler (sink) Pre-flushing 4 × 10
3
Post-flushing 5 × 10
2
CFU/L: colony-forming units per liter.
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tures are equivocal, a negative result in urinary antigen
tests should not be a reason for ruling out the disease.
Our patient was first empirically treated with clari-
thromycin to cover possible intracellular atypical
respiratory pathogens [13]. After the isolation of the
infectious agent, this treatment was not replaced with
other antibiotics such as levofloxacin [14], because of
the prompt clinical response to this macrolide and
because of the previous poor response to a regimen
with an antibiotic containing fluoroquinolone (ciproflox-
acin). Indeed, the use of a fluoroquinole (ciprofloxacin)
not specific for pulmonary infections and the short
course (eight days) of treatment in a severely immuno-
suppressed patient could concur with the recurrence of
respiratory symptoms and could have induced the third
hospitalization.
Colonization of water systems by Legionella spp.
occurs in hospitals throughout the world [15]. In hospi-
tal wards where immunosuppressed patients are sub-
jected to chemotherapy drugs, hot water systems should
be free of Legionella contamination.
The water system of our hospital was colonized by L.
pneumophila of different serogroups. Although various
methods to control Legionella in water distribution sys-
tems have been described in the literature (for example,
methods based on physical or chemical treatments or
both), none of these treatments is able to eradicate the
bacterium permanently, and re-colonization occurs as
soon as the treatments are interrupted [16]. Also, in our
experience, the ineffectiveness of hyperchlorination
treatments in eradicating L. pneumophila was demon-
strated by the re-growth of Legionella only one month
later to levels similar to those observed before treat-
ment. This suggests a need for continuous monitoring
and a maintenance regime for the hospital plumbing
system, particularly in wards accommodating high-risk
patients.
Conclusions
This case report demonstrates that (a) culture of
respiratory secretions and real-time PCR for L. pneumo-
phila should be part of the routine microbiological test-
ing of BAL fluid from immunocompromised patients
with pulmonary infiltrates, (b) a negative result from a
u r i n a r ya n t i g e nt e s td o e sn o tr u l eo u tt h ep r e s e n c eo f
legionellosis, and (c) the monitoring of the Legionella
species in hospital water systems can help to bring in
control measures to reduce the bacterial load and is
therefore a proactive strategy for the control of the
Legionella infection in hospitalized patients.
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